Santander to Buy TSB for £2.6bn, AstraZeneca CEO Eyes US Listing
ByAinvest
Thursday, Jul 3, 2025 11:40 pm ET1min read
AZN--
BA--
SAN--
SPR--
Santander has agreed to buy TSB for £2.6bn, solidifying its presence in the UK. AstraZeneca's CEO considers relocating the company's listing to the US. Sir Keir Starmer's welfare bill faces opposition, causing a multibillion-pound hole in public finances. US Federal Reserve chair Jerome Powell blames Donald Trump's tariffs for preventing immediate interest rate cuts. Boeing takes control of Spirit AeroSystems' Belfast plant, while Marks & Spencer's online business is set to recover from a cyberattack.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet